Showing results (141-150 of 154) with videos related to
Sort By:
Pageof 16
Plos One|September 1, 2016
A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic MyelofibrosisVibe Skov, Mark Burton, Mads Thomassen, et al.Ugeskrift for Laeger|October 28, 2021
[Elevated blood cell counts and vascular disease with the myeloproliferative neoplasms as model diseases]Hans Carl Hasselbalch, Trine Alma Knudsen, Anders Lindholm Sørensen, et al.Microbiology Spectrum|September 11, 2023
Pronounced gut microbiota signatures in patients with JAK2V617F-positive essential thrombocythemiaChristina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Henrik V Nielsen, et al.Blood Advances|October 19, 2022
The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatmentChristina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Lee O'Brien Andersen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNetTiziano Barbui, Giovanni Barosi, Gunnar Birgegard, et al.Journal of Internal Medicine|November 6, 2025
The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all-cause mortalityMorten Kranker Larsen, Vibe Skov, Lasse Kjær, et al.Cancer Medicine|June 23, 2018
Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosisStine Ulrik Mikkelsen, Lasse Kjaer, Mads Emil Bjørn, et al.Blood Cancer Journal|February 8, 2024
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal studyMorten Kranker Larsen, Vibe Skov, Lasse Kjær, et al.European Journal of Haematology|January 16, 2024
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasmsChristina Schjellerup Eickhardt-Dalbøge, Henrik V Nielsen, Kurt Fuursted, et al.Leukemia|March 9, 2018
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNetTiziano Barbui, Ayalew Tefferi, Alessandro M Vannucchi, et al.Pageof 16